The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial. [electronic resource]
Producer: 20040430Description: 529-39 p. digitalISSN:- 1083-8791
- Adolescent
- Adult
- Bone Marrow Transplantation -- adverse effects
- Carmustine -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease Management
- Etoposide -- administration & dosage
- Female
- Hodgkin Disease -- complications
- Humans
- Male
- Middle Aged
- Prognosis
- Proportional Hazards Models
- Salvage Therapy -- methods
- Survival Analysis
- Transplantation Conditioning -- adverse effects
- Transplantation, Autologous
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.